A patient will started on primaquine to treat active Plasmodium vivax malaria, specifically to target the hepatic forms of the parasite. Before you administer the drug you should screen the patient to assess their relative risk of developing a relatively common and severe response to the drug. What is that primaquine-associated risk

<variant>hemolytic disease